CoChat

Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials

Open access
Fornaro, Michele, Stubbs, Brendon, De Berardis, Domenico, Perna, Giampaolo, Valchera, Alessandro, Veronese, Nicola, Solmi, Marco, Ganança, Licínia · 2016 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

Evidence supporting the use of second generation antipsychotics (SGAs) in the treatment of acute depression with mixed features (MFs) associated with bipolar disorder (BD) is scarce and equivocal. Therefore, we conducted a systematic review and preliminary meta-analysis investigating SGAs in the treatment of acute BD depression with MFs. Two authors independently searched major electronic databases from 1990 until September 2015 for randomized (placebo-) controlled trials (RCTs) or open-label clinical trials investigating the efficacy of SGAs in the treatment of acute bipolar depression with MFs. A random-effect meta-analysis calculating the standardized mean difference (SMD) between SGA and placebo for the mean baseline to endpoint change in depression as well as manic symptoms score was computed based on 95% confidence intervals (CI). Six RCTs and one open-label placebo-controlled studies (including post-hoc reports) representing 1023 patients were included. Participants received either ziprasidone, olanzapine, lurasidone, quetiapine or asenapine for an average of 6.5 weeks across the included studies. Meta-analysis with Duval and Tweedie adjustment for publication bias demonstrated that SGA resulted in significant improvements of (hypo-)manic symptoms of bipolar mixed depression as assessed by the means of the total scores of the Young Mania Rating Scale (YMRS) (SMD −0.74, 95% CI −1.20 to −0.28, n SGA = 907, control = 652). Meta-analysis demonstrated that participants in receipt of SGA (n = 979) experienced a large improvement in the Montgomery–Åsberg Depression Rating Scale (MADRS) scores (SMD −1.08, 95% CI −1.35 to −0.81, p < 0.001) vs. placebo (n = 678). Publication and measurement biases and relative paucity of studies. Overall, SGAs appear to offer favorable improvements in MADRS and YMRS scores vs. placebo. Nevertheless, given the preliminary nature of the present report, additional original studies are required to allow more reliable and clinically definitive conclusions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms17020241

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart of the study.
Figure 1 Flowchart of the study.CC BY · PubMed Central
Figure 2 Forest plot of the Young Mania Rating Scale (YMRS) across the included studies. CI = confidence intervals. Referenced studies: McIntyre R.S. et al., 2015 [29]; Patkar A. et al., 2012 [33] & Pae C.U. et al., 2012 [34].
Figure 2 Forest plot of the Young Mania Rating Scale (YMRS) across the included studies. CI = confidence intervals. Referenced studies: McIntyre R.S. et al., 2015 [29]; Patkar A. et al., 2012 [33] & Pae C.U. et al., 2012 [34].CC BY · PubMed Central
Figure 3 Forest plot of the Montgomery–Åsberg Depression Rating Scale (MADRS) across the included studies. Referenced studies: Tohen M. et al., 2014 [14]; Patkar A. et al., 2012 [33] & Pae C.U. et al., 2012 [34]; Berk M. et al., 2015 [31]; McIntyre R.S. et al., 2015 [29].
Figure 3 Forest plot of the Montgomery–Åsberg Depression Rating Scale (MADRS) across the included studies. Referenced studies: Tohen M. et al., 2014 [14]; Patkar A. et al., 2012 [33] & Pae C.U. et al., 2012 [34]; Berk M. et al., 2015 [31]; McIntyre R.S. et al., 2015 [29].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Research works printed but not linked: 1

  1. Prieto, 2013, Exploratory factor analysis of mixed depression utilizing a modified version of Hypomania Checklist 32 (mHCL-32), Bipolar Disord., 15, 114

Cited by

See all 53

Metadata

Authors
Fornaro, M., Stubbs, B., De Berardis, D., Perna, G., Valchera, A., Veronese, N., Solmi, M., & Ganança, L.
Affiliations
  • Columbia University (US)
  • King's College London (GB)
  • National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital. Mazzini, ASL 4, Teramo 64100, Italy
  • Hermanas Hospitalarias del Sagrado Corazón de Jesús (IT)
  • University of Padua (IT)
  • University of Lisbon (PT)
Corresponding author
Fornaro, Michele
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2016-02-16
Volume
17
Issue
2
Pages
241
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2284122467
Cited by
53
References
60
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 7 · 2018: 7 · 2017: 11 · 2016: 5
FWCI
1.43
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
  • Columbia Academic Commons (Columbia University)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
atypical antipsychotics, bipolar depression, mixed features, bipolar disorder, acute depression, manic symptoms, depressive symptoms, ziprasidone, olanzapine, lurasidone, quetiapine, asenapine, Young Mania Rating Scale, Montgomery-Asberg Depression Rating Scale
MeSH terms
Bipolar Disorder, Depression, Humans, Antipsychotic Agents, Treatment Outcome, Controlled Clinical Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials. https://app.cochat.ai/papers/10.3390/ijms17020241
The paper
Fornaro, M., Stubbs, B., De Berardis, D., Perna, G., Valchera, A., Veronese, N., Solmi, M., & Ganança, L. (2016). Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms17020241

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.